
Molecular Crystals and Liquid Crystals p. 84 - 98 (2011)
Update date:2022-08-02
Topics:
Thaker
Kanojiya
Mesogens with a chalcone central linkage are rare. It is believed that the chalcone linkage is not conducive to mesomorphism. But when chalcone linkage is present with other central linkages like azomethine, ester or azo it becomes condusive to mesomorphism. In the present study two new homologous series viz. 1-(4'-butyloxybiphenyl-4-yl)-3-(4-alkoxyphenyl) prop-2-en-1-one (Series-I) and 4-[3-(4'-butoxybiphenyl-4-yl)-3-oxoprop-1-en-1-yl] phenyl 4-alkoxybenzoate (Series-II) were synthesized having the chalcone as a central linkage. Series-I having only chalcone central linkage through it exhibit mesomrphism due to the presence of alkoxy biphenyl group at one end which is rich source to provide to increase linearity and rigidity of the molecule. Series-II which contains chalcone as well as ester as a central linkage and it also exhibit mesomorphism. The compounds of the both series have been characterized by standard methods. Their liquid crystalline properties have been investigated by optical polarizing microscopy and DSC studies. Copyright Taylor & Francis Group, LLC.
View MoreWuhan Zenuo Biological Medicine Technology Co Ltd
website:http://www.znobio.com/a/lianxiwomen/
Contact:(+86-27)8700-2750
Address:Floor 19th,No.76,Longyang Road
Laizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Chemieliva Pharmaceutical Co., Ltd.
website:http://www.chemieliva.com
Contact:+86-23-67770219
Address:99 Longhua Road, Yubei District, 401147, Chongqing, China Email: sales@chemieliva.com Tel:0086-23-67770219 Fax: 0086-23-67770220 Attn: Andy Huang
Chengdu Green technology Co.,Ltd.
Contact:86-28-82608355
Address:C9 ,Economic Headquarters, Economic Development Zone, Chengdu.
Sichuan Jisheng BioPharmaceutical Co., Ltd.
website:http://www.jisheng-peptide.com/
Contact:86-833-2598983
Address:No. 3, Jianye Road, High-tech Zone, Leshan City, Sichuan, China
Doi:10.1016/j.tetasy.2011.08.013
(2011)Doi:10.1039/JR9410000353
()Doi:10.1039/c5ra04593b
(2015)Doi:10.1016/j.bmc.2014.09.034
(2014)Doi:10.1021/ma201846m
(2011)Doi:10.1039/c9sc02670c
(2019)